These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 18309101)

  • 1. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
    David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
    Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
    Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
    Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
    J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
    Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
    J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the ALK1 ligands, BMP9 and BMP10.
    Li W; Salmon RM; Jiang H; Morrell NW
    Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
    Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations.
    Ricard N; Bidart M; Mallet C; Lesca G; Giraud S; Prudent R; Feige JJ; Bailly S
    Blood; 2010 Sep; 116(9):1604-12. PubMed ID: 20501893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
    Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
    Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
    Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
    Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
    J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
    Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
    Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
    Kim JH; Peacock MR; George SC; Hughes CC
    Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.
    Bidart M; Ricard N; Levet S; Samson M; Mallet C; David L; Subileau M; Tillet E; Feige JJ; Bailly S
    Cell Mol Life Sci; 2012 Jan; 69(2):313-24. PubMed ID: 21710321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
    Tong Z; Guo J; Glen RC; Morrell NW; Li W
    Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
    Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.
    Mitchell D; Pobre EG; Mulivor AW; Grinberg AV; Castonguay R; Monnell TE; Solban N; Ucran JA; Pearsall RS; Underwood KW; Seehra J; Kumar R
    Mol Cancer Ther; 2010 Feb; 9(2):379-88. PubMed ID: 20124460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.